Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetics of Gemtuzumab Ozogamicin (GO) Therapy in Acute Myeloid Leukemia

NCT01407757 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01407757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01407757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetics of Gemtuzumab Ozogamicin (GO) Therapy in Acute Myeloid Leukemia
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
July 31, 2011
Completion date
Not reported
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia